332 related articles for article (PubMed ID: 17255777)
1. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
[TBL] [Abstract][Full Text] [Related]
2. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
3. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
6. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
7. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
Yu H; Pinkus GS; Hornick JL
Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin as a marker for mesothelioma.
Kimura N; Kimura I
Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of p63 detection for differentiating primary from metastatic skin adenocarcinomas.
Ivan D; Diwan AH; Lazar AJ; Prieto VG
J Cutan Pathol; 2008 Sep; 35(9):880-1. PubMed ID: 18796086
[No Abstract] [Full Text] [Related]
10. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
11. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin.
Mahalingam M; Nguyen LP; Richards JE; Muzikansky A; Hoang MP
Mod Pathol; 2010 May; 23(5):713-9. PubMed ID: 20190734
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
14. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
[TBL] [Abstract][Full Text] [Related]
15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center.
Sariya D; Ruth K; Adams-McDonnell R; Cusack C; Xu X; Elenitsas R; Seykora J; Pasha T; Zhang P; Baldassano M; Lessin SR; Wu H
Arch Dermatol; 2007 May; 143(5):613-20. PubMed ID: 17515511
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin is a useful marker for identifying mesothelioma in malignant effusions.
Hanna A; Pang Y; Bedrossian CW; Dejmek A; Michael CW
Diagn Cytopathol; 2010 Apr; 38(4):264-9. PubMed ID: 20146302
[TBL] [Abstract][Full Text] [Related]
18. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin.
Ivan D; Hafeez Diwan A; Prieto VG
Mod Pathol; 2005 Jan; 18(1):137-42. PubMed ID: 15389254
[TBL] [Abstract][Full Text] [Related]
19. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
Ordóñez NG
Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
